STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
130
13F, latest reported quarter
What the filings say about CLVT
Insiders, 180 days
-$3.2M net sold
1 buyer · 1 seller · 0% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$4.9M
1 notice
Clarivate insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, CLARIVATE PLC insiders sold a net $3.2M of stock across 39 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
6 earlier Form 4 trades (code P or S) here by this insider (6 buys), the last on Oct 31, 2025.
-17.5% median (-14.6% mean) 90-day return after 6 previous buys.
The trade is 29.4% of the 6,819,742 shares held after it.
No other insider sold within 30 days.
130 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Snyder Andrew Miles sold about $3.9M of CLVT on Aug 3, 2026, the largest insider sale at the company on our record; 130 funds added in the latest 13F quarter.
39 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
CLVT planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Andrew Miles Snyder
Filed 2026-08-03
$4.9M
CLVT mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Clarkston Fund
$3.6M position · as of 2026-06-30
11.9%
Clarkston Founders Fund
$7.7M position · as of 2026-06-30
10.6%
Clarkston Partners Fund
$25.4M position · as of 2026-06-30
8.7%
Invenomic Fund
$11.1M position · as of 2026-07-31
1.3%
BAYWOOD SOCIALLYRESPONSIBLE FUND
$170.6K position · as of 2026-06-30
0.6%
LSV Small Cap Value Fund
$1.2M position · as of 2026-07-31
0.2%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Second PEO
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2023
$12.5M
$10.6M
$5.7M
-69%
+45%
2021
$5.3M
$2.8M
$4.4M
-21%
+43%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $3.2M sold by insiders over 180 days, 130 funds added last quarter, $4.9M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$2.4B
four quarters, 2025-04-01 to 2026-03-31
Revenue, TTM CLVT
FY Dec 2025
$2.5B
FY Dec 2024
$2.6B
FY Dec 2023
$2.6B
FY Dec 2022
$2.7B
FY Dec 2021
$1.9B
Mar 2026
$585.5M
Dec 2025
$617.0M
Sep 2025
$623.1M
Jun 2025
$621.4M
Mar 2025
$593.7M
Dec 2024
$663.0M
Sep 2024
$622.2M
Jun 2024
$650.3M
At each fiscal year end
Single quarter
Net margin, TTM
-5.6%
net income over revenue, 2025-04-01 to 2026-03-31
Net margin, TTM CLVT
FY Dec 2025
-8.2%
FY Dec 2024
-24.9%
FY Dec 2023
-34.7%
FY Dec 2022
-148.9%
FY Dec 2021
-14.4%
Mar 2026
-6.9%
Dec 2025
+0.5%
Sep 2025
-4.5%
Jun 2025
-11.6%
Mar 2025
-17.5%
Dec 2024
-28.9%
Sep 2024
-10.5%
Jun 2024
-46.8%
At each fiscal year end
Single quarter
Free cash flow, TTM
$333.9M
operating cash flow minus capex, 2025-04-01 to 2026-03-31
Free cash flow, TTM CLVT
FY Dec 2025
$365.3M
FY Dec 2024
$357.5M
FY Dec 2023
$501.7M
FY Dec 2022
$306.4M
FY Dec 2021
$205.3M
Mar 2026
$78.9M
Dec 2025
$89.2M
Sep 2025
$115.5M
Jun 2025
$50.3M
Mar 2025
$110.3M
Dec 2024
$59.1M
Sep 2024
$126.3M
Jun 2024
$60.3M
At each fiscal year end
Single quarter
Debt to equity
0.90x
long-term 2026-03-31 plus current 2021-12-31 (51 months older than the period end); equity 2026-03-31
Debt to equity CLVT
FY Dec 2025
0.90x
FY Dec 2024
0.89x
FY Dec 2023
0.79x
FY Dec 2022
0.74x
FY Dec 2021
0.46x
Mar 2026
0.90x
Dec 2025
0.90x
Sep 2025
0.91x
Jun 2025
0.91x
Mar 2025
0.91x
Dec 2024
0.89x
Sep 2024
0.85x
Jun 2024
0.83x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.14x
TTM operating cash flow over long-term 2026-03-31 plus current 2021-12-31 (51 months older than the period end)
Cash flow to debt CLVT
FY Dec 2025
0.14x
FY Dec 2024
0.14x
FY Dec 2023
0.16x
FY Dec 2022
0.10x
FY Dec 2021
0.06x
Mar 2026
0.14x
Dec 2025
0.14x
Sep 2025
0.14x
Jun 2025
0.14x
Mar 2025
0.14x
Dec 2024
0.14x
Sep 2024
0.15x
Jun 2024
0.14x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
-2.8%
TTM net income over average of 2025-03-31 and 2026-03-31
Return on equity CLVT
FY Dec 2025
-4.0%
FY Dec 2024
-11.4%
FY Dec 2023
-14.2%
FY Dec 2022
-42.3%
FY Dec 2021
-2.6%
Mar 2026
-2.8%
Dec 2025
-4.0%
Sep 2025
-7.6%
Jun 2025
-8.2%
Mar 2025
-12.2%
Dec 2024
-11.4%
Sep 2024
-21.1%
Jun 2024
-19.3%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-1.2%
TTM net income over average of 2025-03-31 and 2026-03-31
Return on assets CLVT
FY Dec 2025
-1.8%
FY Dec 2024
-5.3%
FY Dec 2023
-6.8%
FY Dec 2022
-23.2%
FY Dec 2021
-1.5%
Mar 2026
-1.2%
Dec 2025
-1.8%
Sep 2025
-3.4%
Jun 2025
-3.7%
Mar 2025
-5.5%
Dec 2024
-5.3%
Sep 2024
-10.1%
Jun 2024
-9.4%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on invested capital CLVT
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+1.3%
operating income (EBIT proxy) over average of 2025-03-31 and 2026-03-31 minus current liabilities
Return on capital employed CLVT
FY Dec 2025
+0.7%
FY Dec 2024
-2.6%
FY Dec 2023
-6.3%
FY Dec 2022
-25.6%
FY Dec 2021
-0.5%
Mar 2026
+1.3%
Dec 2025
+0.7%
Sep 2025
-0.3%
Jun 2025
-0.5%
Mar 2025
-2.9%
Dec 2024
-2.6%
Sep 2024
-8.9%
Jun 2024
-8.2%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
P/E, trailing CLVT
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$5.3B
market value at close 2026-10-23 on 2026-03-31 shares, plus long-term 2026-03-31 plus current 2021-12-31 (51 months older than the period end), minus cash 2026-03-31
Enterprise value CLVT
FY Dec 2025
$6.2B
FY Dec 2024
$7.9B
FY Dec 2023
$10.5B
FY Dec 2022
$10.3B
FY Dec 2021
$20.1B
Mar 2026
$5.7B
Dec 2025
$6.2B
Sep 2025
$6.7B
Jun 2025
$7.1B
Mar 2025
$6.9B
Dec 2024
$7.9B
Sep 2024
$9.4B
Jun 2024
$8.1B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+27.9%
TTM free cash flow over market value at close 2026-10-23
FCF yield CLVT
FY Dec 2025
+16.5%
FY Dec 2024
+9.9%
FY Dec 2023
+8.2%
FY Dec 2022
+5.4%
FY Dec 2021
+1.4%
Mar 2026
+20.6%
Dec 2025
+16.5%
Sep 2025
+13.2%
Jun 2025
+12.0%
Mar 2025
+13.3%
Dec 2024
+9.9%
Sep 2024
+8.3%
Jun 2024
+10.5%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
PEG, trailing CLVT
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
Jun 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
CLVT ranks highest on institutional and government (60th percentile) and insider conviction (54th), and lowest on risk and compliance (19th), among Software & IT peers.
Profitability
51
Inputs
Return on equity-2.8% · 46 pct, sector of 286
Return on assets-1.2% · 54 pct, sector of 381
Return on invested capitalpre-tax loss, no effective tax rate to apply
Return on capital employed+1.3% · 54 pct, sector of 294
Financial health
31
Inputs
Debt to equity0.90x · 23 pct, sector of 288
Cash flow to debt0.14x · 40 pct, sector of 241
Growth
36
Inputs
Revenue growth, YoY-4.0% · 23 pct, sector of 480
Backlog growth, YoY+9.4% · 49 pct, sector of 182
Insider conviction
54
Inputs
Net Form 4 buying (codes P and S), 180d-$3.2M · 40 pct, sector of 285
Insider buyers, 180d1 · 69 pct, sector of 290
Institutional and government
60
Inputs
Funds adding, latest quarter130 · 60 pct, sector of 415
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
19
Inputs
Short interest, % of float+10.3% · 25 pct, sector of 530
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+26.0% · 14 pct, sector of 316
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
CLVT filings, in plain words
Are Clarivate insiders buying or selling CLVT?
In the 180 days to 2026-10-27, Clarivate insiders were net sellers, a net $3.2M: $1.7M of purchases and $4.8M of sales reported on Form 4, by 1 buyer and 1 seller.
Are there planned insider sales of CLVT?
Yes. 1 Form 144 notice of planned insider sales was filed in the 90 days to 2026-10-27, covering $4.9M of stock; the latest, by Andrew Miles Snyder, was filed 2026-08-03.
Read the full summary
In the 180 days to 2026-10-27, Clarivate insiders were net sellers of CLVT, a net $3.2M across purchases and sales reported on Form 4 by 1 buyer and 1 seller. None of the 3 insider sales was flagged as made under a Rule 10b5-1 plan. Insiders filed 1 Form 144 notice of intent to sell in the 90 days to 2026-10-27, covering $4.9M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.